Tumor Deposits in Colorectal Cancer and Its Prognostic Value in Survival and Metastasis

Launched by MINIA UNIVERSITY · Mar 13, 2025

Keywords

ClinConnect Summary

This clinical trial is studying the importance of tumor deposits in patients with colorectal cancer, specifically looking at how these deposits can affect survival rates and the chances of the cancer spreading to other parts of the body. Researchers want to better understand the role of these deposits in patients with Stage I to III colorectal cancer, as knowing more about them could help doctors make better treatment decisions.

To participate in this trial, you need to be at least 18 years old and have been diagnosed with colorectal cancer that has confirmed tumor deposits. Unfortunately, if you have received certain treatments before surgery or if your cancer is not solely colorectal, you may not be eligible. If you join the trial, you can expect to undergo assessments related to your cancer and its characteristics. This research is important because it aims to provide valuable insights that could improve cancer care and outcomes for future patients.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Age above 18 years old.
• • Both sexes.
• • All Colorectal cancer patients From Stage I to III Colorectal cancer with pathologically positive Tumor deposits.
• Exclusion Criteria:
• • Patient took neoadjuvant therapy.
• • No information available on tumor deposits.
• • Colorectal cancer is not the only primary cancer.
• • Patients with incomplete information about follow-up.